Clinical trial
CATIE-Alzheimer's Disease Trial
NCT00015548
Study timeline
Study start (unknown)2001-03-01Date precision: month
Registry last updated2015-06-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Alzheimer's Diseaseunresolved
Interventions
OlanzapineDRUG · verified · RxNorm: olanzapine
QuetiapineDRUG · verified · RxNorm: quetiapine
RisperidoneDRUG · verified · RxNorm: risperidone
CitalopramDRUG · verified · RxNorm: citalopram
Sponsors & collaborators
National Institute of Mental Health (NIMH)lead sponsor
Mapped research locations
New YorkNew York, United States2Los AngelesCalifornia, United States2ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San DiegoCalifornia, United States1TampaFlorida, United States1DurhamNorth Carolina, United States1New HavenConnecticut, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00015548 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.